Is pain body surface area a valid method to assess pain in hospitalized youth with sickle cell disease? | oneSCDvoice
  • Join Today!

Become a member and connect with:

  • An Active Online Community
  • Articles and Advice on SCD
  • Help Understanding Clinical Trials
abstracts & posters

Is pain body surface area a valid method to assess pain in hospitalized youth with sickle cell disease?

key information

source: The Journal of Pain

year: 2014

authors: J. Santanelli, W. Zempsky, E. O'Hara, T. New, K. Smith-Whitley, J. Casella

summary/abstract:

Youth with sickle cell disease (SCD) are frequently hospitalized for painful vaso-occlusive episodes (VOE). The self-reported body surface area impacted by pain (PBSA) on a body map has been utilized in pain populations as a pain assessment tool. To further demonstrate the validity of PBSA impacted by pain 157 children and adolescents with SCD, ages 7-21, hospitalized for VOE were evaluated at four urban children’s hospitals. In addition to PBSA subjects completed 3 measures assessing their pre-hospital experience in the domains of function (Child’s Activity Limitations Interview (CALI-21)), pain burden (Sickle Cell Pain Burden Interview-Youth (SCPBI-Y)), and quality of life (Pediatric Quality of Life Inventory (PedsQL))and 5 measures reflecting their acute experience: average pain over the previous 24 hours (11-point [0-10] Numeric Rating Scale (NRS)), measures of function (Children’s Acute Pain-Functional Ability Questionnaire (CAP-FAQ)) and (the FIM), mood (Positive Affect Negative Affect Scale (PANAS)).

Mean age was 15.7 years (IQR 12.9 – 18.7 years of age); 55% were females; 85% were African- American. The frequency of body location for pain reported within this population was as follows: legs (67%), back (53%), arms (43%), chest (39%), abdomen (25%), head (24%), and face (5%). PBSA demonstrated significant weak correlations with the measures of function (CALI: r=0.17, p=0.04) (CAP-FAQ: r=0.27, p=0.001), pain (r=0.21, p=0.01), pain burden (r=0.27, p=0.001), mood (r=-0.21, p=0.01), quality of life (r=-0.17, p=0.04), as well as length of stay (r=0.18, p=0.03). This study provides further evidence that the PBSA may be an appropriate tool for assessing pain in SCD youth hospitalized for VOE. PBSA should be considered as a standard measure to be utilized in the assessment of pain in hospitalized youth with VOE.

organisation: Connecticut Children's Medical Center, Hartford, CT

DOI: 10.1016/j.jpain.2014.01.013

read more

expertly curated content related to this topic